Subscribe

Kiri Industries Limited (KIRIINDUS.NS)

INR396.80 -2.30 (-0.58%)
IN NSE Basic Materials Chemicals - Specialty
Address Plot No 299/1/A & B 382445
Ahmedabad, IN
CEO Manishbhai Pravinchandra Kiri
Website kiriindustries.com
IPO 2008-04-22
ISIN INE415I01015

Explore sections of this company profile

Also trades on Bombay Stock Exchange · KIRIINDUS.BO (INR) National Stock Exchange of India · KIRIINDUS.NS (INR)
Description

Kiri Industries Limited (KIL) is an enterprise focused on the manufacturing and worldwide sale of dyes, dye intermediates, and various basic chemicals. The company offers a diverse portfolio of dyes, including reactive, acid/metal complex, and wool reactive varieties. Additionally, KIL supplies essential chemical substances like sulphuric acid, chlorosulfonic acid, oleum, spent sulphuric acid, and thionyl chloride. Its production extends to numerous dye intermediates, such as sulpho J.acid, sulpho tobias acid, sulpho gama acid, para nitro toluene ortho sulfonic acid, H-Acid, acetanilide, and other specialized intermediate compounds. These offerings find extensive application across multiple industrial sectors, including textiles, paper, apparel, hosiery, automotive, carpets, leather, home furnishings, and industrial fabrics. Originally founded as Kiri Dyes and Chemicals Limited in 1998, the company adopted its current name, Kiri Industries Limited, in March 2011. KIL is headquartered in Ahmedabad, India.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
INR396.80 -2.30 (-0.58%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
237.0K
Beta
-0.18
Float Shares
32.89M
Free Float %
50.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+2.79% +1.56% -0.06% -9.31% -30.10% -43.33% -33.48% +41.55% -11.75% +105.71% +161.12%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
396.80
DCF (Levered) 86.46 -78.2%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Quality scores
Altman Z-Score
3.43
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Chemicals - Specialty: +4.7%
    +13.5% ★ Q1'26: +22.2% (vs Q1'25)
  • ✓
    EPS growth Chemicals - Specialty: +13.2%
    +1,789.1% ★ Q1'26: +737.0% (vs Q1'25)
  • ✗
    FCF margin FCF growth · Chemicals - Specialty: +44.1%
    -219.3% Q1'26: -18.9% (vs Q1'25)
  • ✗
    EBIT margin Chemicals - Specialty: +8.8%
    -31.9% Q1'26: -61.6% (vs Q1'25)
  • ✗
    ROIC Chemicals - Specialty: +5.6%
    -10.9% Q1'26: -15.6% (vs Q1'25)
  • ✓
    Share dilution Chemicals - Specialty: +0.1%
    -7.6% ★ Q1'26: -4.6% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    -0.19× Q1'26: -0.07× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.24) × ERP
WACC = 98% × Ke + 2% × Kd (466.6%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 396.80
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2011
actual 		Mar 2017
actual 		Mar 2018
actual 		Mar 2019
actual 		Mar 2020
actual 		Mar 2021
actual 		Mar 2022
actual 		Mar 2023
actual 		Mar 2026
1 Rev. Ana.
1 EPS Ana. 		Mar 2027
1 Rev. Ana.
1 EPS Ana. 		Mar 2028
1 Rev. Ana.
1 EPS Ana. 		Mar 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
38.07B
est: 16.80B (+126.6%)
11.23B
est: 11.36B (-1.2%)
11.01B
est: 11.74B (-6.2%)
13.54B
est: 12.71B (+6.5%)
12.68B
est: 15.89B (-20.2%)
9.42B
est: 17.80B (-47.1%)
14.73B
est: 22.01B (-33.1%)
9.45B
est: 27.23B (-65.3%)
11.74B
11.74B – 11.74B
-56.9% YoY
12.71B
12.71B – 12.71B
+8.3% YoY
15.89B
15.89B – 15.89B
+25.0% YoY
17.80B
17.80B – 17.80B
+12.0% YoY
EBITDA
976.90M
est: 722.58M (+35.2%)
1.61B
est: 488.70M (+229.6%)
1.83B
est: 504.84M (+261.5%)
2.39B
est: 546.82M (+336.7%)
4.50B
est: 683.41M (+558.5%)
848.33M
est: 765.42M (+10.8%)
1.23B
est: 6.12B (-79.8%)
-341.41M
est: 1.18B (-129.0%)
504.84M
504.84M – 504.84M
-57.1% YoY
546.82M
546.82M – 546.82M
+8.3% YoY
683.41M
683.41M – 683.41M
+25.0% YoY
765.42M
765.42M – 765.42M
+12.0% YoY
EBIT
-152.14M
est: -162.97M (+6.6%)
1.32B
est: -110.22M (+1,296.8%)
3.78B
est: -113.86M (+3,416.1%)
2.01B
est: -123.33M (+1,731.9%)
4.06B
est: 1.83B (+121.5%)
387.05M
est: -172.63M (+324.2%)
731.07M
est: 1.99B (-63.3%)
-830.23M
est: -265.41M (-212.8%)
-113.86M
-113.86M – -113.86M
+57.1% YoY
-123.33M
-123.33M – -123.33M
-8.3% YoY
-154.13M
-154.13M – -154.13M
-25.0% YoY
-172.63M
-172.63M – -172.63M
-12.0% YoY
Net Income
-2.78B
est: 2.66B (-204.3%)
2.66B
est: 6.82B (-60.9%)
3.58B
est: 6.44B (-44.4%)
1.64B
est: 8.68B (-81.1%)
3.76B
est: 3.94B (-4.7%)
2.52B
est: 4.38B (-42.3%)
3.89B
est: 5.20B (-25.3%)
1.07B
est: 3.26B (-67.3%)
5.95B
5.95B – 5.95B
+82.1% YoY
8.02B
8.02B – 8.02B
+34.9% YoY
3.64B
3.64B – 3.64B
-54.6% YoY
4.04B
4.04B – 4.04B
+11.1% YoY
SGA
9.45B
est: 1.79B (+427.5%)
324.36M
est: 1.21B (-73.2%)
363.47M
est: 1.25B (-71.0%)
377.38M
est: 1.36B (-72.2%)
581.69M
est: 1.59B (-63.4%)
500.97M
est: 1.90B (-73.6%)
613.47M
est: 2.66B (-76.9%)
524.15M
est: 2.92B (-82.0%)
1.25B
1.25B – 1.25B
-57.1% YoY
1.36B
1.36B – 1.36B
+8.3% YoY
1.69B
1.69B – 1.69B
+25.0% YoY
1.90B
1.90B – 1.90B
+12.0% YoY
EPS
-166.75
est: 39.79 (-519.0%)
95.39
est: 101.98 (-6.5%)
124.92
est: 96.23 (+29.8%)
52.36
est: 129.86 (-59.7%)
114.49
est: 58.93 (+94.3%)
75.10
est: 65.45 (+14.7%)
95.57
est: 56.39 (+69.5%)
20.58
est: 48.58 (-57.6%)
96.23
96.23 – 96.23
+98.1% YoY
129.86
129.86 – 129.86
+34.9% YoY
58.93
58.93 – 58.93
-54.6% YoY
65.45
65.45 – 65.45
+11.1% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-27 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-26 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-25 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-22 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-21 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-20 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-19 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-18 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-15 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-14 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-13 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-12 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-11 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-08 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-07 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-06 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-05 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-05-04 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-04-30 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-04-29 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-04-28 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-04-27 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-04-24 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-04-23 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-04-22 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-04-21 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-04-20 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-04-17 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5
2026-04-16 C 2/5 3/5 1/5 1/5 1/5 3/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-851.90M
OE per share TTM
-12.69
Owner's Yield
-3.38%
Maintenance CapEx ratio
460.20%
Maint CapEx / Avg PPE
74.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-3.40M
Shares Outstanding
65.17M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Manishbhai Pravinchandra Kiri MD, Chief Executive Officer & Executive Chairman 16M male
Girish H. Tandel Chief Technology Officer & Whole Time Director 2M male
Yagnesh Mankad Whole Time Director 1M male
Mukeshbhai Dave Chief Operating Officer — male
Neelima Rajput President - Sales & Marketing — female
Pareshkumar Vyas Chief Operating Officer of Intermediates & Chemicals — male
Prasanna Patankar Chief Marketing Officer — male
Shailika Soni Vice President of HR — female
Suresh Savajibhai Gondalia Company Secretary & Compliance Officer — male
Jayesh Vyas Chief Financial Officer — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals - Specialty